# A Study to Evaluate the Effects of Itraconazole on MK-1708 in Healthy Participants (MK-1708-003)

> **NCT06586606** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 12 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** MK-1708
- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT06586606
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-03
- **Primary completion:** 2024-12-10
- **Final completion:** 2024-12-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06586606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06586606, "A Study to Evaluate the Effects of Itraconazole on MK-1708 in Healthy Participants (MK-1708-003)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06586606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*